Four years of tenofovir monotherapy for NUC naive field practice European patients suppresses HBV replication in most patients with a favorable renal safety profile but does not prevent HCC in patients with or without cirrhosis

Lampertico P., Soffredini R., Yurdaydin C., İDİLMAN R., Papatheodoridis G. V., Margariti E., ...Daha Fazla

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, cilt.58 identifier

  • Yayın Türü: Bildiri / Özet Bildiri
  • Cilt numarası: 58
  • Basıldığı Şehir: Washington
  • Basıldığı Ülke: Kiribati
  • Ankara Üniversitesi Adresli: Evet